Beta-Hemolytic Streptococci and Necrotizing Soft Tissue Infections
Trond Bruun1,2, Eivind Rath3, Oddvar Oppegaard3
1Department of Clinical Science, University of Bergen, Bergen, Norway. trond.bruun@helse-bergen.no.
Abstract:
β-hemolytic streptococci are major causes of necrotizing soft tissue infections (NSTIs), Streptococcus pyogenes (group A streptococcus; GAS) in particular. NSTIs caused by Streptococcus dysgalactiae (SD) have also been reported. In the INFECT cohort of 409 NSTIs patients, more than a third of the cases were caused by GAS (31%) or SD (7%). Risk factors of streptococcal NSTIs compared to streptococcal cellulitis have previously been largely unknown. The INFECT study confirmed blunt trauma as an important risk factor. In addition, absence of pre-existing skin lesions and a lower BMI were associated with NSTIs. The study also confirmed that septic shock is more frequent in GAS cases than in other types of NSTIs. Septic shock was also among several predictors of mortality. The role of intravenous immunoglobulin (IVIG) in streptococcal NSTIs has been unclear. In the INFECT cohort, IVIG treatment was associated with increased survival. As in other studies, a significant microbial diversity was observed, but with predominance of a few emm types. Overall, the INFECT study gives a comprehensive and contemporary picture of the clinical characteristics and the microbes involved in streptococcal NSTIs. The reported severity of disease underscores the need for new efforts aimed at identifying novel diagnostic measures and improved treatment.
Insights
Necrotizing soft tissue infections (NSTIs) caused by Streptococcus pyogenes (GAS) and Streptococcus dysgalactiae (SD) are severe. Blunt trauma, lack of skin lesions, and lower BMI are risk factors for these infections, with IVIG improving survival.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- β-hemolytic streptococci, particularly Streptococcus pyogenes (group A streptococcus; GAS), are primary causes of necrotizing soft tissue infections (NSTIs).
- Streptococcus dysgalactiae (SD) also causes NSTIs, though less frequently reported.
- Risk factors differentiating streptococcal NSTIs from cellulitis were not well-established.
Purpose of the Study:
- To investigate the clinical characteristics, risk factors, and outcomes of NSTIs caused by GAS and SD.
- To evaluate the effectiveness of intravenous immunoglobulin (IVIG) in treating streptococcal NSTIs.
- To analyze microbial diversity and identify predominant emm types in streptococcal NSTIs.
Main Methods:
- Analysis of the INFECT cohort, comprising 409 patients with NSTIs.
- Comparison of risk factors between NSTIs and streptococcal cellulitis.
- Assessment of outcomes, including septic shock and mortality, and the impact of IVIG treatment.
Main Results:
- GAS accounted for 31% and SD for 7% of NSTIs in the cohort.
- Blunt trauma, absence of pre-existing skin lesions, and lower BMI were identified as risk factors for NSTIs.
- Septic shock was more frequent in GAS cases and predicted mortality; IVIG treatment was associated with increased survival.
Conclusions:
- Streptococcal NSTIs, particularly those caused by GAS, are severe infections with identifiable risk factors.
- IVIG may improve survival rates in patients with streptococcal NSTIs.
- Further research is needed for novel diagnostics and improved treatments for these serious infections.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Bacterial Phylum Spirochaetes
Endocarditis I: Introduction
Special Staining Techniques
Bacterial Phylum Actinobacteria
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.


